Cassava Sciences said the FDA had placed a hold on its trial for a drug to treat epilepsy. Shares slid 13% to $2.49 after the bell. KB Home delivered fewer homes and recorded a lower profit in its ...
Nike made some progress with its turnaround plan in the fiscal second quarter, but expects to return to a sales decline in the current quarter, as weakness in China continues. Executives at the ...
The Goldman Sachs U.S. Equity Insights Fund returned 8.24% in Q3 2025, outperforming the S&P 500 by 12 bps. Click here to ...
Third-quarter buybacks rose 9.9% vs. a year earlier to $249 billion. Apple, Nvidia, Google and Meta Platforms led the way.
Investing.com-- U.S. stock index futures steadied on Wednesday evening following blowout earnings and positive guidance from chipmaker Micron Technology, with focus turning squarely to upcoming ...
U.S. stocks climbed after cooler-than-expected inflation data eased rate worries. November CPI fell to 2.7%, below forecasts.
Major stock indexes surged Thursday after delayed Consumer Price Index data came in better than expected, with the blue-chip ...
The Dow, S&P 500, and Nasdaq rallied Thursday after the November CPI report. The Dow and S&P 500 snapped four-day losing streaks.
U.S. stocks rose following an encouraging report on inflation that could help the Federal Reserve keep cutting interest rates next year.